EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Emerging clinical applications of exosomes in breast cancer management from biomarkers to therapeutics

Xiangmei Wu, Wenjing Wang

Discover Oncology · 21.01.2026 · 17 (1)

DOI: 10.1007/s12672-026-04417-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Discover Oncology, online erschienen am 21.01.2026. Verfasst von Xiangmei Wu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Beijing Geriatric Hospital, Beijing, 100095, PR China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Exosomes, nano-sized extracellular vesicles carrying distinct molecular cargoes inherited from their parent cells, have emerged as critical mediators of intercellular communication in cancer. In breast cancer, tumor-derived exosomes (TDEs) possess unique molecular signatures and demonstrate remarkable potential in reshaping the tumor microenvironment, modulating immune responses, and driving disease progression. Growing evidence supports the diagnostic utility of TDEs in early detection and molecular subtyping of breast cancer, particularly via non-invasive liquid biopsy approaches. Meanwhile, exosomes in the breast cancer tumor microenvironment mediate intercellular communication and transmit pro-tumorigenic signals among various cell populations, thereby playing a pivotal role in promoting cell proliferation, angiogenesis, and tumor metastasis. On the therapeutic front, two strategies are attracting growing attention: inhibition of exosome biogenesis or reduction of circulating TDEs to disrupt tumor communication, and the engineering of exosomes as targeted delivery systems for drugs, RNAs, or immune modulators. Collectively, this review summarizes the current understanding of exosome biology in breast cancer and highlights the translational potential of both native and engineered exosomes as diagnostic and therapeutic tools. Continued research into exosome mechanisms and technologies will undoubtedly accelerate their integration into precision oncology.

Schlagwörter

Stichwörter der Autor:innen

Breast cancerEngineered exosomesExosomesLiquid biopsyTumor microenvironment

Autor:innen und Institutionen

  • Department of Pathology, Beijing Geriatric Hospital, Beijing, 100095, PR China.
  • Beijing Institute of Hepatology, Beijing YouAn Hospital, Capital Medical University, Xitoutiao RD No. 8, Fengtai District, Beijing, 100069, P.R. China. wangwenjing85321@ccmu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wu, X., & Wang, W. (2026). Emerging clinical applications of exosomes in breast cancer management from biomarkers to therapeutics. Discover Oncology, 17(1). https://doi.org/10.1007/s12672-026-04417-2

Vancouver

Wu X, Wang W. Emerging clinical applications of exosomes in breast cancer management from biomarkers to therapeutics. Discover Oncology. 2026;17(1). doi:10.1007/s12672-026-04417-2

BibTeX
@article{Wu2026,
  author = {Wu, Xiangmei and Wang, Wenjing},
  title = {Emerging clinical applications of exosomes in breast cancer management from biomarkers to therapeutics},
  journal = {Discover Oncology},
  year = {2026},
  volume = {17},
  number = {1},
  doi = {10.1007/s12672-026-04417-2}
}
Kostenlos starten →